Synapsoft logo
AI Insights from Disclosures
Searching...
WSI Co., Ltd. 299170
Searching...

Company Summary

Quarterly Performance Revenue Operating Margin

Market Sentiment

※ Click the graph to view AI analysis information for that month.
Revenue
Consolidated
Separate
Operating Income
Consolidated
Separate
Net Income
Consolidated
Separate

Financials

Excel

No financial data is available for this period.
~
Quarterly
Annual
No data is available for this period.

*Values beyond the fourth decimal place of the unit are displayed as '0/-0'

Financial Indicator Forecast

※ These forecasts are simple AI estimates based on historical data and may differ from actual results.

Company Overview

as of June 2026
WSI Co., Ltd. supplies pharmaceuticals and medical devices to spine and joint medical institutions in South Korea and abroad, based on the proven sales expertise of personnel from Wooridul Spine Hospital, South Korea's first spine specialty hospital with long-standing know-how in the spine and joint medical device market, by proactively satisfying the diverse interests of market participants, including medical institutions, regulatory authorities, insurance organizations, and distributors. The company's main source of revenue is the wholesale and retail of pharmaceuticals and medical devices, with its flagship product being a topical hemostatic agent, a pharmaceutical.
Representative Director Lee Yunseok
Founded May 11, 2018
Corporation Type KOSDAQ
Industry Classification Wholesale of household goods
Corporate number 11011-6748507
Business number 236-81-01193
Phone Number 02-6952-2839
Fax Number 02-6915-5804
Company Address 47 Samhaksa-ro, Songpa-gu, Seoul
Products & Services

Financial Health

Executives

Employees

Shareholders

Industry revenue

Disclosures

Comments

0 / 255

AI Assistant